Alfacalcidol - CAS 41294-56-8
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
Alfacalcidol
Catalog Number:
B0084-068405
Synonyms:
1-Hydroxycholecalciferol; Alfarol; EinsAlpha; Alpha-Calcidol; One-Alpha; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
CAS Number:
41294-56-8
Description:
A synthetic analog of Calcitiol (the hormonal form of vitamin D3), which shows identical potency with respect to stimulation of intestinal calcium absorption and bone mineral mobilization. Vitamin D source.
Molecular Weight:
400.65
Molecular Formula:
C27H44O2
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
InChI:
InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1
InChIKey:
OFHCOWSQAMBJIW-AVJTYSNKSA-N
Targets:
VD/VDR
Catalog Number Size Price Stock Quantity
B0084-068405 50 mg $398 In stock
Bulk Inquiry
Chemical Structure
CAS 41294-56-8 Alfacalcidol

Related VD/VDR Products


CAS 1262843-46-8 25-Hydroxy VD2-D6

25-Hydroxy VD2-D6
(CAS: 1262843-46-8)

A labelled metabolite of Vitamin D2

CAS 112875-61-3 Impurity of Calcipotriol

Impurity of Calcipotriol
(CAS: 112875-61-3)

Impurity of Calcipotriol; Calcipotriol (MC 903; Calcipotriene) is a ligand of VDR-like receptors.

CAS 57333-96-7 Tacalcitol

Tacalcitol
(CAS: 57333-96-7)

Tacalcitol promotes normal bone development by regulating calcium and modulates immunological and inflammatory processes. lt induces nerve growth factor product...

CAS 40013-87-4 24, 25-Dihydroxy VD3

24, 25-Dihydroxy VD3
(CAS: 40013-87-4)

24, 25-Dihydroxy VD3 is a compound which is closely related to 1,25-dihydroxyvitamin D3, the active form of vitamin D3, but like vitamin D3 itself and 25-hydrox...

CAS 129831-99-8 MC 976

MC 976
(CAS: 129831-99-8)

MC 969 is an analog of the calcemic drug 1α-hydroxyvitamin D3 (1α-OH-D3) in which carbons 25, 26, and 27 in the side chain are incorporated into a cyclopropane ...

CAS 55721-11-4 Secalciferol

Secalciferol
(CAS: 55721-11-4)

Secalciferol is a metabolite of Vitamin D, a possibly anti-inflammatory steroid which is involved in bone ossification. lt mediates calcium and phosphorus homeo...

CAS 112828-09-8 (24R)-MC 976

(24R)-MC 976
(CAS: 112828-09-8)

(24R)-MC 976 is a Vitamin D3 derivative.

CAS 21343-40-8 Ercalcidiol

Ercalcidiol
(CAS: 21343-40-8)

A metabolite of Vitamin D2

CAS 457048-34-9 1α, 24, 25-Trihydroxy VD2

1α, 24, 25-Trihydroxy VD2
(CAS: 457048-34-9)

1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.

CAS 147657-22-5 Calcipotriol monohydrate

Calcipotriol monohydrate
(CAS: 147657-22-5)

Calcipotriol increased hCAP18 mRNA expression in IL-17/IL-22-stimulated keratinocytes. However, LL37 peptide in the culture supernatants was reduced by calcipot...

CAS 82266-85-1 Impurity C of Alfacalcidol

Impurity C of Alfacalcidol
(CAS: 82266-85-1)

Impurity C of Alfacalcidol is impurity of Alfacalcidol, which is a non-selective VDR activator medication. Alfacalcidol improves mechanical bone strength and bo...

CAS 112827-99-3 24R-Calcipotriol

24R-Calcipotriol
(CAS: 112827-99-3)

24R-Calcipotriol is an impurity of Calcipotriol, which is a ligand of VDR-like receptors.

CAS 103909-75-7 Maxacalcitol

Maxacalcitol
(CAS: 103909-75-7)

Maxacalcitol is non-calcemic vitamin D3 analog and ligand of VDR-like receptors.

CAS 60133-18-8 Ercalcitriol

Ercalcitriol
(CAS: 60133-18-8)

Ercalcitriol is a active metabolite of vitamin D2. It exhibits equipotent antirachitic activity in rats as calcitriol.

CAS 83805-11-2 Falecalcitriol

Falecalcitriol
(CAS: 83805-11-2)

Falecalcitriol is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.

CAS 67-97-0 Cholecalciferol

Cholecalciferol
(CAS: 67-97-0)

Cholecalciferol is a naturally occuring form of vitamin D which is obtained from dietary sources, such as fish, or through the conversion of 7-dehydrocholestero...

CAS 163018-26-6 3-O-(2-Aminoethyl)-25-hydroxyvitamin D3

3-O-(2-Aminoethyl)-25-hydroxyvitamin D3
(CAS: 163018-26-6)

Vitamin D3 analog.

CAS 112849-14-6 (24S)-MC 976

(24S)-MC 976
(CAS: 112849-14-6)

(24S)-MC 976 is a Vitamin D3 derivative.

CAS 63283-36-3 Calcifediol monohydrate

Calcifediol monohydrate
(CAS: 63283-36-3)

Calcifediol monohydrate is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxyl...

Reference Reading


1.High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients.
Jean G1, Chazot C, Bresson E, Zaoui E, Cavalier E. Nephron. 2016;132(3):181-90. doi: 10.1159/000443845. Epub 2016 Feb 19.
BACKGROUND: Sclerostin is an osteocyte hormone that decreases osteoblastogenesis. Sclerostin may play a key role in osteoporosis and also in vascular calcification (VC). In chronic kidney disease and haemodialysis (HD) patients, serum sclerostin levels are high.
2.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M1,2, Che RC1,2, Hu CY1,2, Du XH1,2, Ding GX1,2, Huang SM1,2, Chen Y3,4,5, Zhang AH1,2. World J Pediatr. 2016 May;12(2):236-42. doi: 10.1007/s12519-015-0058-7. Epub 2015 Dec 18.
BACKGROUND: The information about the use of off-label drugs in pediatric nephrology is still lacking, which leads to increased adverse reactions and medical disputes. We retrospectively analyzed the use of off-label drugs in the in-patient ward of the nephrology department of Nanjing Children's Hospital, China in order to provide more complete information about the use of drugs for children.
3.Effects of 1α-Calcidol (Alfacalcidol) on Microvascular Endothelial Function, Arterial Stiffness, and Blood Pressure in Type II Diabetic Nephropathy Patients.
Munisamy S1, Daud KM2, Mokhtar SS1, Rasool AH1. Microcirculation. 2016 Jan;23(1):53-61. doi: 10.1111/micc.12256.
OBJECTIVES: To determine the effects of six months alfacalcidol on microvascular endothelial function, arterial stiffness, and BP in DN patients.
4.Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry.
Huish SA1, Fletcher S2, Dunn JA3, Hewison M4, Bland R5. J Steroid Biochem Mol Biol. 2016 Feb 11. pii: S0960-0760(16)30023-1. doi: 10.1016/j.jsbmb.2016.02.009. [Epub ahead of print]
Low serum 25(OH)D and associated bone and non-bone related problems are not well appreciated in end stage renal disease (ESRD). Vitamin D treatment strategies in the UK currently focus almost exclusively on calcitriol [1,25(OH)2D], alfacalcidol or paricalcitol. In ESRD hypovitaminosis D is associated with bone loss, muscle weakness, falls, fractures and increased inflammation. National guidelines changed in 2014 and now recommend the diagnosis and treatment of low serum 25(OH)D in all patients with glomerular filtration rate (GFR) less than 30ml/min/1.73m2. However as yet there are no standardized guidelines for dosage, frequency and monitoring in ESRD patients. Following a systematic review of the literature we developed a clinical guideline for cholecalciferol supplementation at University Hospitals of Coventry and Warwickshire, UK. The guideline recommends 40,000IU cholecalciferol weekly for patients with 25(OH)D <50nmol/L and 20,000IU weekly for patients with 25(OH)D 50-75nmol/L; to be continued long term unless levels increase to ≥150nmol/L.